Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
NOVT
Upturn stock ratingUpturn stock rating

Novanta Inc (NOVT)

Upturn stock ratingUpturn stock rating
$134.47
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/13/2025: NOVT (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

4 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $147.32

1 Year Target Price $147.32

Analysts Price Target For last 52 week
$147.32Target price
Low$98.76
Current$134.47
high$187.12

Analysis of Past Performance

Type Stock
Historic Profit -23.05%
Avg. Invested days 42
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/13/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 4.68B USD
Price to earnings Ratio 66.67
1Y Target Price 147.32
Price to earnings Ratio 66.67
1Y Target Price 147.32
Volume (30-day avg) 4
Beta 1.46
52 Weeks Range 98.76 - 187.12
Updated Date 06/30/2025
52 Weeks Range 98.76 - 187.12
Updated Date 06/30/2025
Dividends yield (FY) -
Basic EPS (TTM) 1.95

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 7.42%
Operating Margin (TTM) 12.84%

Management Effectiveness

Return on Assets (TTM) 5.75%
Return on Equity (TTM) 9.73%

Valuation

Trailing PE 66.67
Forward PE -
Enterprise Value 5013773284
Price to Sales(TTM) 4.91
Enterprise Value 5013773284
Price to Sales(TTM) 4.91
Enterprise Value to Revenue 5.27
Enterprise Value to EBITDA 27.46
Shares Outstanding 35970800
Shares Floating 35633066
Shares Outstanding 35970800
Shares Floating 35633066
Percent Insiders 0.86
Percent Institutions 103.17

Analyst Ratings

Rating 2
Target Price 147.32
Buy 2
Strong Buy 1
Buy 2
Strong Buy 1
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Novanta Inc

stock logo

Company Overview

overview logo History and Background

Novanta Inc. was founded in 1997 as GSI Lumonics, later rebranded as Novanta in 2013. It has grown through strategic acquisitions and organic growth, focusing on precision photonic and motion control components and subsystems.

business area logo Core Business Areas

  • Precision Medicine and Manufacturing: Designs, manufactures, and sells optical, photonic, and electronic components and subsystems used in medical and advanced industrial applications. Includes laser beam steering, precision microfluidics and laser micro machining.
  • Vision: Develops and delivers imaging solutions, primarily for machine vision and inspection applications. These offerings include embedded vision, cameras, and illumination solutions.
  • Robotics: Provides automation solutions for robotic surgery, lab automation and robotic assembly. Products include precision motors, encoders, and integrated motion solutions.

leadership logo Leadership and Structure

Novanta Inc. is led by Matthijs Glastra as CEO. The company operates with a functional organizational structure across its various business segments. The Board of Directors provides oversight and strategic direction.

Top Products and Market Share

overview logo Key Offerings

  • Laser Beam Steering Components: Components used in laser marking, cutting, and welding systems. Market share data is difficult to ascertain precisely, but Novanta is a significant player in this sector, competing with companies like Scanlab and Coherent Corp. Revenue is integrated across precision medicine and manufacturing segment. The competition includes companies like Scanlab GmbH and Coherent Corp (COHR).
  • Precision Motion Control Systems: Products include servo drives, motors, and encoders used in various industrial automation and medical applications. Competes with providers such as Moog (MOG.A) and Kollmorgen. Revenue is integrated across precision medicine and manufacturing and robotics segments.
  • Medical Grade Power Solutions: Designs and manufactures standard and custom power conversion solutions for medical applications. Competitors include companies like Advanced Energy (AEIS) and SL Power Electronics. Market data is difficult to ascertain precisely as revenue is not broken out into segments.

Market Dynamics

industry overview logo Industry Overview

The markets Novanta serves are experiencing growth driven by increasing demand for automation, precision manufacturing, and advanced medical technologies. Aging populations and the need for minimally invasive procedures are also fueling demand.

Positioning

Novanta is positioned as a key supplier of enabling technologies for OEMs in its target markets. Its competitive advantages include its broad product portfolio, technical expertise, and global presence.

Total Addressable Market (TAM)

The estimated TAM for Novanta's served markets is in the billions of dollars. They are positioned well to capture a significant portion of this TAM with their diverse product offerings and strong market presence. Although the exact figures are not readily available, the market is vast, with increasing growth prospects.

Upturn SWOT Analysis

Strengths

  • Diversified product portfolio
  • Strong market position in niche applications
  • Technical expertise and innovation
  • Global presence
  • Acquisition expertise

Weaknesses

  • Dependence on specific industries and customers
  • Exposure to economic cycles
  • Integration risks associated with acquisitions
  • High valuation relative to peers

Opportunities

  • Expanding into new geographic markets
  • Developing new products and applications
  • Acquiring complementary businesses
  • Leveraging technology to improve efficiency

Threats

  • Increased competition
  • Technological obsolescence
  • Economic downturn
  • Supply chain disruptions
  • Geopolitical risks

Competitors and Market Share

competitor logo Key Competitors

  • COHR
  • MOG.A
  • AEIS

Competitive Landscape

Novanta competes based on its technological expertise, breadth of product offerings, and strong customer relationships. Its smaller size can be an advantage in terms of agility and focus, but a disadvantage in terms of resources compared to larger competitors.

Major Acquisitions

Laser Optek GmbH

  • Year: 2021
  • Acquisition Price (USD millions): 178
  • Strategic Rationale: Expands Novanta's presence in the medical aesthetics market and adds complementary laser technology.

Growth Trajectory and Initiatives

Historical Growth: Novanta has demonstrated strong historical growth through a combination of organic initiatives and strategic acquisitions.

Future Projections: Analysts project continued growth for Novanta, driven by increasing demand for its products and services in its target markets. Revenue growth in the high single digits to low teens is forecasted.

Recent Initiatives: Recent initiatives include acquisitions to expand product offerings and market reach, as well as investments in research and development to drive innovation.

Summary

Novanta is a strong company with a diversified product portfolio and solid market position in its niche segments. Its strategic acquisitions have fueled growth, but the company must manage integration risks and maintain its technological edge. Positive cash flow and a healthy balance sheet support its growth strategy, although economic cycles and increased competition pose ongoing challenges. Overall, Novanta appears to be well positioned for future growth, but execution is critical.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company filings (10-K, 10-Q), Investor presentations, Industry reports, Analyst estimates
  • Yahoo Finance
  • Google Finance
  • Company website

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on thorough research and consultation with a qualified financial advisor. Market share data is based on estimates and may not be precise.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Novanta Inc

Exchange NASDAQ
Headquaters Bedford, MA, United States
IPO Launch date 2016-01-04
CEO & Chairman of the Board Mr. Matthijs Glastra
Sector Technology
Industry Scientific & Technical Instruments
Full time employees 3000
Full time employees 3000

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. It operates in two segments, Automation Enabling Technologies and Medical Solutions. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam delivery components, laser beam delivery solutions, CO2 lasers, solid state lasers, ultrafast lasers, optical and inductive encoders, precision motors, integrated stepper motors, servo drives, motion control solutions, intelligent robotic end-of-arm technology solutions, and air bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications. The Medical Solutions segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; laser beam delivery solutions; video processing, streaming, and capture; machine vision technologies; radio frequency identification (RFID) technologies; barcode identification technologies; thermal chart recorders; light and color measurement technologies; touch panel displays; and advanced motion control solutions. The company sells its products through its direct sales force and distributors under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, General Scanning, ATI Industrial Automation, Celera Motion, IMS, MicroE, Applimotion, Zettlex, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was incorporated in 1968 and is headquartered in Bedford, Massachusetts.